Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1054 | 2880 | 42.1 | 80% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
237 | 3 | INFLUENZA//RESPIRATORY SYNCYTIAL VIRUS//AVIAN INFLUENZA | 47995 |
76 | 2 | INFLUENZA//AVIAN INFLUENZA//INFLUENZA VIRUS | 27762 |
1054 | 1 | INFLUENZA//M2E//MF59 | 2880 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | INFLUENZA | authKW | 460913 | 19% | 8% | 541 |
2 | M2E | authKW | 343044 | 1% | 83% | 39 |
3 | MF59 | authKW | 273603 | 2% | 59% | 44 |
4 | INFLUENZA VACCINE | authKW | 263586 | 6% | 14% | 181 |
5 | AS03 | authKW | 255928 | 1% | 93% | 26 |
6 | HETEROSUBTYPIC IMMUNITY | authKW | 234597 | 1% | 76% | 29 |
7 | PANDEMIC | authKW | 218089 | 6% | 13% | 162 |
8 | H5N1 | authKW | 210819 | 4% | 16% | 128 |
9 | UNIVERSAL VACCINE | authKW | 210755 | 1% | 76% | 26 |
10 | HEMAGGLUTININ | authKW | 179621 | 5% | 13% | 132 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Virology | 39657 | 28% | 0% | 816 |
2 | Immunology | 35761 | 53% | 0% | 1529 |
3 | Medicine, Research & Experimental | 12653 | 25% | 0% | 727 |
4 | Infectious Diseases | 6178 | 14% | 0% | 413 |
5 | Microbiology | 2299 | 13% | 0% | 374 |
6 | Biotechnology & Applied Microbiology | 882 | 9% | 0% | 253 |
7 | Multidisciplinary Sciences | 112 | 1% | 0% | 38 |
8 | Biochemical Research Methods | 106 | 3% | 0% | 87 |
9 | Parasitiology | 50 | 1% | 0% | 33 |
10 | Medicine, General & Internal | 47 | 4% | 0% | 107 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INFLUENZA | 222177 | 6% | 11% | 184 |
2 | VIRAL PROD | 95325 | 2% | 15% | 62 |
3 | VIRAL PSEUDOTYPE UNIT | 69376 | 0% | 55% | 12 |
4 | UNIT ANTIVIRAL IMMUN GENET THER Y | 66358 | 0% | 52% | 12 |
5 | JEBSEN INFLUENZA VACCINE | 61673 | 0% | 73% | 8 |
6 | INFLUENZA BRANCH | 43262 | 1% | 16% | 25 |
7 | HPFB | 42742 | 0% | 37% | 11 |
8 | CRUCELL VACCINE | 38158 | 0% | 60% | 6 |
9 | INFLAMMAT IMMUN INFECT | 37099 | 1% | 15% | 23 |
10 | VACCINE EVALUAT | 33693 | 1% | 13% | 24 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | VACCINE | 173564 | 19% | 3% | 543 |
2 | INFLUENZA AND OTHER RESPIRATORY VIRUSES | 45429 | 2% | 7% | 60 |
3 | EXPERT REVIEW OF VACCINES | 27600 | 2% | 5% | 57 |
4 | HUMAN VACCINES & IMMUNOTHERAPEUTICS | 24849 | 2% | 4% | 63 |
5 | CLINICAL AND VACCINE IMMUNOLOGY | 15403 | 2% | 2% | 62 |
6 | JOURNAL OF VIROLOGY | 12126 | 7% | 1% | 215 |
7 | JOURNAL OF INFECTIOUS DISEASES | 9698 | 4% | 1% | 128 |
8 | HUMAN VACCINES | 5119 | 1% | 3% | 16 |
9 | ANTIVIRAL RESEARCH | 4128 | 1% | 1% | 37 |
10 | VIRAL IMMUNOLOGY | 4056 | 1% | 2% | 21 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INFLUENZA | 460913 | 19% | 8% | 541 | Search INFLUENZA | Search INFLUENZA |
2 | M2E | 343044 | 1% | 83% | 39 | Search M2E | Search M2E |
3 | MF59 | 273603 | 2% | 59% | 44 | Search MF59 | Search MF59 |
4 | INFLUENZA VACCINE | 263586 | 6% | 14% | 181 | Search INFLUENZA+VACCINE | Search INFLUENZA+VACCINE |
5 | AS03 | 255928 | 1% | 93% | 26 | Search AS03 | Search AS03 |
6 | HETEROSUBTYPIC IMMUNITY | 234597 | 1% | 76% | 29 | Search HETEROSUBTYPIC+IMMUNITY | Search HETEROSUBTYPIC+IMMUNITY |
7 | PANDEMIC | 218089 | 6% | 13% | 162 | Search PANDEMIC | Search PANDEMIC |
8 | H5N1 | 210819 | 4% | 16% | 128 | Search H5N1 | Search H5N1 |
9 | UNIVERSAL VACCINE | 210755 | 1% | 76% | 26 | Search UNIVERSAL+VACCINE | Search UNIVERSAL+VACCINE |
10 | HEMAGGLUTININ | 179621 | 5% | 13% | 132 | Search HEMAGGLUTININ | Search HEMAGGLUTININ |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KRAMMER, F , PALESE, P , (2015) ADVANCES IN THE DEVELOPMENT OF INFLUENZA VIRUS VACCINES.NATURE REVIEWS DRUG DISCOVERY. VOL. 14. ISSUE 3. P. 167 -182 | 154 | 75% | 51 |
2 | KOLPE, A , SCHEPENS, B , FIERS, W , SAELENS, X , (2017) M2-BASED INFLUENZA VACCINES: RECENT ADVANCES AND CLINICAL POTENTIAL.EXPERT REVIEW OF VACCINES. VOL. 16. ISSUE 2. P. 123 -136 | 83 | 75% | 1 |
3 | WHEATLEY, AK , KENT, SJ , (2015) PROSPECTS FOR ANTIBODY-BASED UNIVERSAL INFLUENZA VACCINES IN THE CONTEXT OF WIDESPREAD PRE-EXISTING IMMUNITY.EXPERT REVIEW OF VACCINES. VOL. 14. ISSUE 9. P. 1227 -1239 | 114 | 86% | 0 |
4 | EPSTEIN, SL , PRICE, GE , (2010) CROSS-PROTECTIVE IMMUNITY TO INFLUENZA A VIRUSES.EXPERT REVIEW OF VACCINES. VOL. 9. ISSUE 11. P. 1325-1341 | 111 | 74% | 44 |
5 | KRAMMER, F , (2016) NOVEL UNIVERSAL INFLUENZA VIRUS VACCINE APPROACHES.CURRENT OPINION IN VIROLOGY. VOL. 17. ISSUE . P. 95 -103 | 68 | 92% | 3 |
6 | HILLAIRE, MLB , OSTERHAUS, ADME , RIMMELZWAAN, GF , (2011) INDUCTION OF VIRUS-SPECIFIC CYTOTOXIC T LYMPHOCYTES AS A BASIS FOR THE DEVELOPMENT OF BROADLY PROTECTIVE INFLUENZA VACCINES.JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. VOL. . ISSUE . P. - | 103 | 72% | 28 |
7 | BAZ, M , LUKE, CJ , CHENG, X , JIN, H , SUBBARAO, K , (2013) H5N1 VACCINES IN HUMANS.VIRUS RESEARCH. VOL. 178. ISSUE 1. P. 78-98 | 99 | 65% | 28 |
8 | KRAMMER, F , PALESE, P , STEEL, J , (2015) ADVANCES IN UNIVERSAL INFLUENZA VIRUS VACCINE DESIGN AND ANTIBODY MEDIATED THERAPIES BASED ON CONSERVED REGIONS OF THE HEMAGGLUTININ.INFLUENZA PATHOGENESIS AND CONTROL - VOL II. VOL. 386. ISSUE . P. 301 -321 | 68 | 76% | 22 |
9 | HASHEM, AM , (2015) PROSPECTS OF HA-BASED UNIVERSAL INFLUENZA VACCINE.BIOMED RESEARCH INTERNATIONAL. VOL. . ISSUE . P. - | 93 | 70% | 0 |
10 | SUBBARAO, K , MATSUOKA, Y , (2013) THE PROSPECTS AND CHALLENGES OF UNIVERSAL VACCINES FOR INFLUENZA.TRENDS IN MICROBIOLOGY. VOL. 21. ISSUE 7. P. 350-358 | 71 | 84% | 20 |
Classes with closest relation at Level 1 |